Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11932648 CDK2 inhibitors

Patent 11932648 was granted and assigned to Blueprint Medicines on March, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Blueprint Medicines

Current Assignee

Blueprint Medicines

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119326480

Patent Inventor Names

Richard Vargas0

Joseph L. Kim0

Neil Bifulco, Jr.0

Natasja Brooijmans0

Steven Mark Wenglowsky0

Philip D. Ramsden0

Emanuele Perola0

Douglas Wilson0

Date of Patent

March 19, 2024

Patent Application Number

178504530

Date Filed

June 27, 2022

Patent Citations

‌

US Patent 8058290 7-substituted aza-indazoles, compositions containing same, production method and use thereof

‌

US Patent 8334291 Aliphatically substituted pyrazolopyridines, and the use thereof

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11932648 CDK2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API